(Q45445693)

14 December 2017

title

Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2. (English)

1 reference

14 December 2017

0 references

1 reference

1 reference

Anke Lührmann

1

1 reference

14 December 2017

Thomas Tschernig

series ordinal

2

1 reference

14 December 2017

Reinhard Pabst

series ordinal

3

1 reference

14 December 2017

Stefan Niewiesk

series ordinal

4

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

14 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

14 December 2017

volume

23

1 reference

14 December 2017

issue

39

1 reference

14 December 2017

page(s)

4721-4726

1 reference

Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Recognition of single-stranded RNA viruses by Toll-like receptor 7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Induction of the measles virus receptor SLAM (CD150) on monocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Discrimination of bacterial lipoproteins by Toll-like receptor 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Recruitment of lymphocytes and dendritic cells from the blood to the bronchoalveolar space and the draining lymph nodes after a single intrabronchial application of the lipopeptide MALP-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Biological activity of immunostimulatory CpG DNA motifs in domestic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Regulation of antibody responses via antibodies, complement, and Fc receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Evaluation of immunogenicity and side effects of triple viral vaccine (MMR) in adults, given by two routes: subcutaneous and respiratory (aerosol).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.009

10.1016/J.VACCINE.2005.05.009

7 January 2021

Identifiers

DOI

1 reference

14 December 2017

1 reference